234 related articles for article (PubMed ID: 9847379)
1. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression.
Shen H; Cheng T; Preffer FI; Dombkowski D; Tomasson MH; Golan DE; Yang O; Hofmann W; Sodroski JG; Luster AD; Scadden DT
J Virol; 1999 Jan; 73(1):728-37. PubMed ID: 9847379
[TBL] [Abstract][Full Text] [Related]
2. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors and the molecular basis for human immunodeficiency virus type 1 entry into peripheral hematopoietic stem cells and their progeny.
Zhao SF; Li W; Dornadula G; Dicker D; Hoxie J; Peiper SC; Pomerantz RJ; Duan LX
J Infect Dis; 1998 Dec; 178(6):1623-34. PubMed ID: 9815214
[TBL] [Abstract][Full Text] [Related]
4. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.
Deichmann M; Kronenwett R; Haas R
Blood; 1997 May; 89(10):3522-8. PubMed ID: 9160656
[TBL] [Abstract][Full Text] [Related]
5. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
Anderson J; Akkina R
Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
[TBL] [Abstract][Full Text] [Related]
7. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.
Lee B; Ratajczak J; Doms RW; Gewirtz AM; Ratajczak MZ
Blood; 1999 Feb; 93(4):1145-56. PubMed ID: 9949156
[TBL] [Abstract][Full Text] [Related]
8. CD34+ cells and their derivatives contain mRNA for CD4 and human immunodeficiency virus (HIV) co-receptors and are susceptible to infection with M- and T-tropic HIV.
Carr JM; Ramshaw HS; Li P; Burrell CJ
J Gen Virol; 1998 Jan; 79 ( Pt 1)():71-5. PubMed ID: 9460925
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.
Majka M; Rozmyslowicz T; Lee B; Murphy SL; Pietrzkowski Z; Gaulton GN; Silberstein L; Ratajczak MZ
J Clin Invest; 1999 Dec; 104(12):1739-49. PubMed ID: 10606628
[TBL] [Abstract][Full Text] [Related]
10. Modulation of CD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1.
Vignoli M; Furlini G; Re MC; Ramazzotti E; La Placa M
J Hematother Stem Cell Res; 2000 Feb; 9(1):39-45. PubMed ID: 10738970
[TBL] [Abstract][Full Text] [Related]
11. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J; Rossi J; Akkina R
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
[TBL] [Abstract][Full Text] [Related]
12. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
[TBL] [Abstract][Full Text] [Related]
14. CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
Sebastian NT; Zaikos TD; Terry V; Taschuk F; McNamara LA; Onafuwa-Nuga A; Yucha R; Signer RAJ; Riddell J; Bixby D; Markowitz N; Morrison SJ; Collins KL
PLoS Pathog; 2017 Jul; 13(7):e1006509. PubMed ID: 28732051
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny.
Hariharan D; Li Y; Campbell DE; Douglas SD; Starr SE; Ho W
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1545-52. PubMed ID: 10580405
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
17. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1.
Yi Y; Rana S; Turner JD; Gaddis N; Collman RG
J Virol; 1998 Jan; 72(1):772-7. PubMed ID: 9420285
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells.
Viardot A; Kronenwett R; Deichmann M; Haas R
Ann Hematol; 1998 Nov; 77(5):193-7. PubMed ID: 9858143
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
[TBL] [Abstract][Full Text] [Related]
20. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]